Item 3. Quantitative and Qualitative Disclosures about Market Risk
1K characters. Original on sec.gov · Markdown
Item 3. Quantitative and Qualitative Disclosures about Market Risk
There have been no material changes in market risk exposures that affect the disclosures presented in “Item 7A. Quantitative and Qualitative Disclosures about Market Risk” in the Company’s 2021 Form 10-K filed on February 25, 2022.
The economy of Turkey was recently determined to be hyperinflationary. Consequently, in accordance with U.S. GAAP, the Company’s monetary assets and liabilities that are subject to remeasurement as a result of the changes in the Turkish lira will change beginning in the second quarter of 2022. This change will have an immaterial impact to Merck’s condensed consolidated financial statements.
Previous: Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations · Next: Item 4. Controls and Procedures